SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Art Baer who wrote (878)9/5/1997 3:56:00 PM
From: DeadHead   of 1172
 
Yes, that's basically what I recall. But why is the Astra branch so much more proactive in getting this test out than Astra-Merck and why did they use another test supplier? Also, I can't help but wonder if Astra-Merck might be reevaluating their strategy to bundle the tests with their treatment.

I'm still holding my shares, but I'd be a fool if I didn't ask "why" now and then. It seems that too much of CMTR's future is riding on this Astra-Merck deal. This is not good.

Still hopeful, but losing faith.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News